Your browser doesn't support javascript.
loading
Contraception Update: Progestin-Only Implants and Injections.
Deshmukh, Prium; Antell, Karen; Brown, Elizabeth J.
Afiliação
  • Antell K; Christiana Care Family Medicine Residency Program, 1401 Foulk Road, Suite 100 Wilmington, Delaware 19803.
  • Brown EJ; Christiana Care Health System Value Institute Ammon Center 2E55, 4755 Ogletown-Stanton Rd, Newark, DE 19718.
FP Essent ; 462: 25-29, 2017 Nov.
Article em En | MEDLINE | ID: mdl-29172413
ABSTRACT
Progestin-only contraception is a popular method of birth control in the United States and worldwide. Progestin-only implants and injections allow patients access to long-term contraception with simple options for reversal or removal. The implant is one of the most effective forms of contraception and there are few contraindications. Manufacturer-led training is required to become certified in insertion and removal. The most common adverse effect of the implant is a change in menstrual bleeding patterns. Little evidence has shown weight gain or decreased bone mineral density with use. The depot medroxyprogesterone acetate (DMPA) injection is used widely and is effective. Adverse effects that may limit use include changes in bleeding patterns and bone mineral density loss, which is reversible after discontinuation. The risk of weight gain with DMPA is greatest in obese adolescents and black patients. There is no significantly increased risk of cancer with either method. Both are safe for use in the postpartum period, during breastfeeding, and immediately after abortion.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Progestinas / Acetato de Medroxiprogesterona / Anticoncepcionais Femininos / Implantes de Medicamento / Serviços de Planejamento Familiar / Medicina de Família e Comunidade Limite: Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Progestinas / Acetato de Medroxiprogesterona / Anticoncepcionais Femininos / Implantes de Medicamento / Serviços de Planejamento Familiar / Medicina de Família e Comunidade Limite: Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article